Recombinant Olfr149 is produced via heterologous expression systems, often with modifications to enhance stability and detection:
| Host System | Tag | Application | Source |
|---|---|---|---|
| Mammalian Cells | His, Avi&Fc | Purification and detection | |
| HEK293T Cells | Flag, Rho, Lucy | Surface expression and functional assays | |
| E. coli | His | High-yield production |
Key engineering strategies include:
Lucy tag: A cleavable N-terminal signal peptide that improves surface expression in HEK293T cells, particularly when co-expressed with chaperones (RTP1S, Ric8b, Gαolf) .
Rho tag: Enhances surface localization but is less effective without the Lucy tag .
Olfr149 mediates odorant recognition through interactions with hydrophobic pockets in transmembrane domains (TM3, TM5, TM6) . While specific ligands remain unidentified, studies highlight:
Expression in olfactory epithelium (OE): RNA-Seq data confirm Olfr149 expression in OE, particularly in fluorescence-activated cell-sorted olfactory receptor neurons (ORNs) .
G-protein coupling: Activates cAMP-dependent pathways, though functional assays require co-expression with Gαolf and chaperones .
Recombinant Olfr149 is utilized in diverse experimental settings:
Improved Surface Expression: The Lucy tag increases surface expression in HEK293T cells to >90% for most ORs when combined with chaperones .
Ligand Binding Specificity: Mutagenesis studies suggest TM3, TM5, and TM6 domains determine odorant selectivity via hydrophobic interactions .
Olfactory Epithelium Specificity: RNA-Seq confirms Olfr149 expression in ORNs, aligning with its role in olfaction .
Olfactory Receptor 149 (Olfr149) is a G protein-coupled receptor expressed in the olfactory epithelium of mice that plays a critical role in the detection of specific odorant molecules. Like other olfactory receptors, Olfr149 follows the "one neuron-one receptor" rule, where each olfactory sensory neuron typically expresses only one olfactory receptor gene. The receptor's activation triggers a signaling cascade that ultimately results in odorant perception. Research suggests that Olfr149 responds to a specific subset of odorant molecules, contributing to the mouse's ability to discriminate between different scents. Understanding Olfr149's activation patterns provides insights into the molecular basis of olfactory coding and odor discrimination in mammals.
Genetic background significantly influences olfactory receptor expression, including Olfr149. Similar to what has been observed with other olfactory receptors like Olfr17, different mouse strains can exhibit variable expression levels due to genetic variations in cis-regulatory regions . For instance, research on Olfr17 has demonstrated that the 129-mouse strain shows higher expression levels compared to the B6 strain, with quantifiable differences in both the number of expressing neurons and transcript levels . These strain-specific differences may result from variations in promoter regions, enhancer elements, or DNA methylation patterns that collectively regulate gene expression. When studying Olfr149, researchers should account for strain-specific variations by clearly documenting the genetic background of their mouse models and potentially comparing expression across different strains to establish baseline differences.
Several experimental models are available for studying Olfr149, each with distinct advantages for particular research questions:
In vivo mouse models: Wild-type mice of different genetic backgrounds (C57BL/6, 129, etc.) allow for comparative expression analysis
Knockout models: Olfr149-deficient mice enable assessment of functional consequences
Knock-in reporter models: Similar to the P2-GFP model used for Olfr17 , where fluorescent proteins are inserted to track expression
Heterologous expression systems: Cell lines (HEK293, Hana3A) transfected with Olfr149 for ligand identification
Ex vivo tissue preparations: Olfactory epithelium explants for electrophysiological and calcium imaging studies
For recombinant protein studies, bacterial (E. coli) and mammalian expression systems have been developed to produce the receptor for structural and biochemical analyses, though membrane protein expression remains technically challenging.
Optimizing recombinant expression of Olfr149 requires addressing several technical challenges inherent to G protein-coupled receptors:
Expression system selection: While E. coli systems offer high yield, mammalian cell lines (HEK293T, CHO) better facilitate proper folding and post-translational modifications essential for functionality. Insect cell systems (Sf9, Hi5) represent an intermediate option with improved yield over mammalian cells.
Vector design considerations:
Include an N-terminal signal sequence to ensure proper membrane trafficking
Incorporate a rhodopsin-derived N-terminal tag to enhance surface expression
Add a C-terminal tag (His, FLAG) for purification while avoiding interference with G protein coupling
Consider codon optimization for the expression system
Co-expression factors: Co-express accessory proteins like Receptor Transporting Proteins (RTPs) and Receptor Expression Enhancing Proteins (REEPs) that facilitate receptor trafficking to the cell surface. The Hana3A cell line, with stably integrated RTP1S, RTP2, and REEP1, has demonstrated superior expression for many olfactory receptors compared to standard HEK293T cells.
Temperature modulation: Lowering incubation temperature to 30-32°C after transfection can improve folding efficiency and reduce degradation of the recombinant receptor.
Functional validation of expressed Olfr149 should employ multiple complementary techniques, including surface immunostaining, calcium imaging, and cAMP accumulation assays to confirm both expression and signaling competence.
Identifying ligands for Olfr149 requires a systematic approach combining multiple screening methodologies:
High-throughput functional screening:
Calcium imaging assays using fluorescent calcium indicators in Olfr149-expressing cells
FLIPR (Fluorescent Imaging Plate Reader) technology for automated detection of receptor activation
cAMP accumulation assays using FRET-based sensors
Luciferase reporter systems driven by cAMP response elements (CRE)
Structure-based virtual screening:
Homology modeling based on solved GPCR structures
Molecular docking of candidate odorants
Molecular dynamics simulations to assess binding stability
Confirmatory assays:
Dose-response analyses to determine EC₅₀ values
Competition binding assays with identified agonists
Single-cell electrophysiology to validate responses in native neurons
When establishing a data table for ligand screening results, organize information systematically as follows:
| Compound | Chemical Class | EC₅₀ (μM) | Efficacy (% max) | Receptor Specificity | Source/Reference |
|---|---|---|---|---|---|
| Compound A | Aldehyde | 15.3 ± 2.1 | 100 | Olfr149-selective | Reference X |
| Compound B | Ketone | 42.7 ± 5.6 | 78 ± 7 | Activates Olfr149 and Olfr151 | Reference Y |
Include experimental conditions as footnotes and clearly specify the assay system used, as results may vary depending on the detection method and expression system employed.
When designing experiments to study Olfr149 expression patterns, implement a comprehensive approach that incorporates multiple complementary techniques:
Tissue selection and preparation:
Main olfactory epithelium (MOE): Separate into dorsal, medial, and ventral zones
Control tissues: Brain regions, non-neural tissues to confirm specificity
Consider developmental timepoints (embryonic, neonatal, adult)
Process tissues consistently with RNase-free conditions for RNA analysis
Quantitative methods:
RT-qPCR: Design primers unique to Olfr149 with minimal cross-reactivity to other olfactory receptors
RNA-seq: For unbiased transcriptome-wide analysis and comparison across tissues
Single-cell RNA-seq: To determine the percentage of olfactory sensory neurons expressing Olfr149
In situ hybridization: To visualize spatial distribution patterns
Experimental controls:
Housekeeping genes: Include at least three stable reference genes (e.g., GAPDH, β-actin, 18S rRNA)
Positive controls: Include primers for known olfactory markers (OMP, Golf)
Negative controls: Non-template controls and tissues known not to express olfactory receptors
When presenting expression data, follow the formatting principles demonstrated in scientific publications3, with clear labeling of independent variables (tissue type, genetic background, developmental stage) and dependent variables (expression level) as shown below:
| Tissue Region | Normalized Olfr149 Expression (ΔCt) | Olfr149+ Neurons/mm² |
|---|---|---|
| Dorsal MOE | 1.00 ± 0.08 | 7.5 × 10⁻⁵ ± 0.6 |
| Medial MOE | 0.65 ± 0.07 | 4.8 × 10⁻⁵ ± 0.5 |
| Ventral MOE | 0.12 ± 0.03 | 0.9 × 10⁻⁵ ± 0.2 |
Analyzing genetic variants of Olfr149 across mouse strains requires a methodical approach that integrates genomic sequencing with functional characterization:
Sequence acquisition and alignment:
Extract genomic DNA from different mouse strains (C57BL/6, 129, BALB/c, etc.)
Amplify the Olfr149 coding region and promoter (approximately 2kb upstream)
Sequence using next-generation sequencing for high coverage
Align sequences against reference genomes using tools like MUSCLE or Clustal Omega
Variant identification and characterization:
Identify single nucleotide polymorphisms (SNPs) and insertions/deletions
Determine if variants affect coding regions (synonymous vs. non-synonymous) or regulatory elements
Analyze conserved binding motifs in promoter regions that might influence expression
Epigenetic characterization:
Functional correlation:
Compare expression levels between strains using RT-qPCR
Quantify the number of neurons expressing Olfr149 per unit area using in situ hybridization
Correlate genetic/epigenetic variations with expression differences
When reporting strain differences, present data similar to that observed with Olfr17, where significant expression differences were documented between mouse strains . A comprehensive table should include:
| Mouse Strain | Promoter Variants | Coding Variants | Methylation Frequency (%) | Neurons Expressing Olfr149/μm² | Relative mRNA Level |
|---|---|---|---|---|---|
| C57BL/6 | Reference | Reference | 72.4 ± 3.5 | 5.8 × 10⁻⁵ ± 0.4 | 1.00 ± 0.06 |
| 129 | -496 G>A, -325 T>C | Coding SNP 1 | 58.2 ± 4.2 | 7.6 × 10⁻⁵ ± 0.5 | 1.31 ± 0.09 |
| BALB/c | -882 A>G | None | 69.7 ± 3.8 | 6.2 × 10⁻⁵ ± 0.5 | 1.08 ± 0.07 |
Detecting low-abundance Olfr149 transcripts presents a significant challenge due to the sparse expression pattern of individual olfactory receptors. The following methods offer increasing sensitivity for accurate detection:
Digital PCR (dPCR):
Provides absolute quantification without reliance on standard curves
Partitions the sample into thousands of individual reactions
Particularly valuable for detecting rare transcripts with higher precision than qPCR
Can reliably detect differences as small as 1.2-fold between samples
Single-cell RNA sequencing (scRNA-seq):
Allows identification of individual Olfr149-expressing neurons
Overcomes dilution effects inherent in whole-tissue analysis
Newer protocols like Smart-seq3 offer improved sensitivity for low-abundance transcripts
Can be coupled with cell sorting to pre-enrich for olfactory sensory neurons
RNAscope in situ hybridization:
Offers single-molecule detection sensitivity in tissue sections
Maintains spatial information about expressing cells
Allows multiplexing to co-localize Olfr149 with cell-type markers
Provides quantifiable signal suitable for comparative analysis
Targeted RNA capture sequencing:
Uses probe sets designed to capture Olfr149 and other olfactory receptor transcripts
Enriches target sequences prior to sequencing, increasing depth of coverage
Cost-effective compared to whole-transcriptome sequencing when focusing on specific gene families
When comparing transcript detection methods, incorporate technical replicates and assess consistency across detection platforms. Based on approaches used for other olfactory receptors , sensitivity limits should be clearly reported:
| Detection Method | Lower Limit of Detection (copies/reaction) | Dynamic Range (orders of magnitude) | Relative Cost | Spatial Information |
|---|---|---|---|---|
| RT-qPCR | ~10 | 6-7 | $ | No |
| Digital PCR | ~1 | 4-5 | $$ | No |
| RNAscope | ~1 | 3-4 | $$$ | Yes |
| scRNA-seq | ~5-10 | 3 | $$$$ | Limited |
Epigenetic modifications play a crucial role in regulating olfactory receptor expression, including Olfr149. Understanding these mechanisms requires investigation of several key factors:
DNA methylation dynamics:
CpG methylation in promoter regions correlates with olfactory receptor silencing
As observed with other olfactory receptors like Olfr17, differential methylation frequencies can occur between alleles and across mouse strains
DNA methylation patterns should be assessed using bisulfite sequencing with specific attention to:
CpG islands in the promoter region (typically 1-2kb upstream)
Enhancer elements, particularly the H element equivalent for the Olfr149 cluster
Gene body methylation, which may affect transcriptional elongation
Histone modifications:
Active olfactory receptor genes associate with euchromatic marks (H3K4me3)
Silent olfactory receptor genes associate with heterochromatic marks (H3K9me3, H3K27me3)
ChIP-seq analysis should target these key modifications across the Olfr149 locus
Compare histone modification patterns between expressing and non-expressing tissues
Chromatin organization:
Nuclear architecture plays a significant role, as olfactory receptor genes cluster in "compartments"
3D chromatin conformation can be assessed using Chromosome Conformation Capture (3C, 4C, Hi-C)
Analyze interchromosomal interactions that may regulate the "one receptor-one neuron" rule
Transcription factor binding:
Identify binding sites for known regulators (Lhx2, Ebf, Olf-1) in the Olfr149 promoter
Perform ChIP-seq to confirm occupancy in expressing versus non-expressing cells
Research on other olfactory receptors has shown that these epigenetic factors do not operate in isolation but interact to establish and maintain expression patterns . When analyzing epigenetic data, integrate multiple layers of information as shown in this example table:
| Gene Region | DNA Methylation (%) | H3K4me3 Enrichment | H3K9me3 Enrichment | Chromatin Accessibility | Expression Level |
|---|---|---|---|---|---|
| Promoter | 78.3 ± 4.2 | Low | High | Closed | Silenced |
| Promoter | 32.4 ± 5.1 | High | Low | Open | Expressed |
| Gene Body | 65.2 ± 3.7 | Moderate | Low | Intermediate | Expressed |
Evaluating Olfr149 activation requires robust assay systems that can reliably detect receptor responses to potential ligands. The following approaches offer complementary information about receptor functionality:
Calcium mobilization assays:
Basis: GPCR activation leads to calcium release from intracellular stores
Implementation options:
Fluorescent calcium indicators (Fluo-4, Fura-2) with plate reader or microscopy detection
Genetically encoded calcium indicators (GCaMP variants) for improved sensitivity
Automated systems like FLIPR for high-throughput screening
Advantages: Rapid response (seconds to minutes), amenable to high-throughput screening
Limitations: May require co-expression of promiscuous G proteins (Gα15/16) for coupling
cAMP-based assays:
Basis: Olfactory receptors couple to Golf, activating adenylyl cyclase and increasing cAMP
Implementation options:
ELISA-based detection of cAMP accumulation
Genetically encoded FRET sensors (EPAC-based) for real-time monitoring
CRE-luciferase reporter systems for amplified signal detection
Advantages: More direct measure of native signaling pathway, good dynamic range
Limitations: Slower response kinetics than calcium assays
Bioluminescence resonance energy transfer (BRET):
Basis: Measures proximity between receptor and signaling proteins in real-time
Implementation options:
Receptor-Rluc and β-arrestin-YFP for monitoring receptor activation and desensitization
G protein dissociation assays using labeled Gα and Gβγ subunits
Advantages: Provides kinetic information, minimal cellular perturbation
Limitations: Requires protein engineering, lower throughput
Electrophysiological recordings:
Basis: Direct measurement of membrane current changes upon receptor activation
Implementation options:
Patch-clamp recording from native neurons or heterologous cells
Field potential recordings from olfactory epithelium preparations
Advantages: Highest temporal resolution, most physiologically relevant
Limitations: Low throughput, technically demanding
When reporting assay performance for Olfr149 activation studies, provide a detailed comparison table:
| Assay System | Signal-to-Noise Ratio | Z'-factor | EC₅₀ Range Detection | Time Resolution | Throughput (compounds/day) |
|---|---|---|---|---|---|
| Calcium imaging | 8.2 ± 1.4 | 0.78 | 1 nM - 100 μM | Seconds | >1000 |
| cAMP-Glo | 5.4 ± 0.9 | 0.65 | 10 nM - 100 μM | Minutes | >500 |
| BRET | 3.8 ± 0.7 | 0.59 | 1 nM - 10 μM | Seconds | ~100 |
| Patch-clamp | 12.5 ± 2.3 | 0.85 | 100 pM - 10 μM | Milliseconds | 5-10 |
Several cutting-edge technologies are poised to transform research on Olfr149 and other olfactory receptors:
Cryo-electron microscopy (cryo-EM):
Recent advances in single-particle cryo-EM have enabled structure determination of challenging membrane proteins
Application to Olfr149 would reveal binding pocket architecture and conformational changes upon activation
Improved detergents and nanodiscs specifically designed for GPCRs enhance stability for structural studies
Combining structural data with molecular dynamics simulations can provide unprecedented insights into ligand recognition mechanisms
CRISPR-based technologies:
CRISPR-Cas9 gene editing allows precise modification of Olfr149 in the native genomic context
CRISPRi/CRISPRa systems enable reversible manipulation of Olfr149 expression
Prime editing permits introduction of specific point mutations without double-strand breaks
Base editing facilitates systematic modification of regulatory elements without selection markers
Organoid and microfluidic systems:
Olfactory epithelium organoids recapitulate the cellular diversity of native tissue
Microfluidic "nose-on-a-chip" platforms allow controlled odorant exposure under physiological conditions
Integration with real-time imaging enables dynamic studies of receptor activation and adaptation
Co-culture systems can model receptor-dependent axon guidance and glomerular formation
Artificial intelligence approaches:
Machine learning algorithms can predict Olfr149 ligands based on physicochemical properties
Deep learning models integrating structural and functional data improve virtual screening efficiency
Natural language processing of the scientific literature can identify overlooked connections between Olfr149 and biological processes
AI-guided experimental design optimizes resource allocation for complex multi-variable experiments
These technologies will collectively enable researchers to address fundamental questions about Olfr149 function, from molecular interactions to systems-level integration in olfactory coding.
Conflicting data about Olfr149 expression or function can arise from numerous sources, including methodological differences, genetic background variations, and environmental factors. The following systematic approach helps reconcile discrepancies:
Methodological standardization:
Compare detection methods (qPCR, RNA-seq, in situ hybridization) for sensitivity and specificity differences
Standardize experimental conditions including tissue collection, processing, and analysis protocols
Implement identical primer/probe sets when comparing across studies
Use absolute quantification methods (digital PCR) to eliminate calibration differences
Genetic background considerations:
Document complete strain information, including substrain designations
Assess strain-specific polymorphisms in the Olfr149 coding and regulatory regions
Consider allele-specific expression patterns as observed with other olfactory receptors
Perform backcrossing experiments to isolate genetic contributions to phenotypic differences
Environmental and developmental factors:
Control for age-dependent expression changes
Document housing conditions (diet, light cycles, temperature) that may affect receptor expression
Consider olfactory experience/exposure history that could modify expression through feedback mechanisms
Evaluate seasonal variations that may influence endocrine factors affecting gene expression
Technical validation across platforms:
Implement orthogonal methods to confirm key findings
Use spike-in controls to establish detection limits
Perform systematic replications in independent laboratories
Consider observer bias in subjective assessments
When presenting reconciliation of conflicting data, organize information in comparative tables that highlight key methodological differences:
| Study | Genetic Background | Age | Detection Method | Tissue Processing | Olfr149 Expression Level | Likely Explanation for Discrepancy |
|---|---|---|---|---|---|---|
| Lab A | C57BL/6J | 8 weeks | RT-qPCR | Fresh frozen | High | Strain-specific expression |
| Lab B | C57BL/6N | 12 weeks | RNA-seq | RNAlater | Moderate | Suboptimal RNA preservation |
| Lab C | C57BL/6J | 8 weeks | In situ | Paraformaldehyde | Low | Less sensitive detection method |
By systematically addressing these variables, researchers can transform apparent contradictions into mechanistic insights about the regulation and function of Olfr149.